NCT03149003 2023-11-15A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial TherapySumitomo Pharma America, Inc.Phase 3 Completed221 enrolled 17 charts